Bright Minds Biosciences to Host Symposium on Therapeutic Developments
Brightmindsbio23 May, 2022Health
Bright Minds Biosciences a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced that Ian McDonald, Chief Executive Officer, Dr. Revati Shreeniwas, Chief Medical Officer, Professor John McCorvy, PhD, Senior Advisor, and other key speakers will host a symposium on the recent therapeutic developments within the Dravet Syndrome landscape.
Related Bookmarks
- What Is the Cost of Surrogacy in Canada? Check All Details
- What Makes Anxiety Treatments Effective?
- Aloe Vera capsules
- Prevention Tips for Hair Loss and Bariatric Surgery
- Flaxseed Health Benefits
- Herbal supplement for strength
- Bariatric Surgery and Relief in Migraine
- BuddyBasket is Canada's premier online store for Paneer and Tofu.
- Vascular Study - Access Health Care Physicians, LLC
- Learn that Proven Diet and Nutrition Habits will Help You Feel Better
Recent Profiles
Marvelous Barber Lounge
Claire Kinsley
922bet
Sc88 Đăng Nhập & Đăng Ký Trang Chủ Sc88
Ethos - Hazleton Cannabis Dispensary
Meteryard
Gamebaidoithuong
Bảng Xếp Hạng Bóng Đá
Toto88live
Scarborough Cochran